Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease
- Nat Genet. 2014 Aug;46(8):812-814. doi: 10.1038/ng.3040.
- 1. Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, EX2 5DW, UK.
- 2. Folkhälsan Institute of Genetics, University of Helsinki, Helsinki, Finland.
- 3. Research Programs Unit, Molecular Neurology, University of Helsinki, Helsinki, Finland.
- 4. Hematology Research Unit Helsinki, Department of Hematology, University of Helsinki.
- 5. Helsinki University Central Hospital Cancer Center, Helsinki, Finland.
- 6. Department of Clinical Sciences, Lund University, Lund, Sweden.
- 7. CRC, Skåne University Hospital SUS, Malmö, Sweden.
- 8. Bristol Royal Hospital for Children, Upper Maudlin Street, Bristol, BS2 8BJ, UK.
- 9. Children's Hospital, Helsinki University Central Hospital, Helsinki, Finland.
- 10. Department of Pediatrics, Kuopio University Hospital, Helsinki, Finland.
- 11. Department of Diabetes and Endocrinology, Children's University Hospital, Temple St., Dublin 1, Ireland.
- 12. Department of Endocrinology, Institute for Mother and Child Health Care of Serbia 'Dr Vukan Cupic', Belgrade, Serbia.
- 13. Immunodeficiency Unit, Division of Infectious Diseases, Helsinki University Central Hospital, Helsinki, Finland.
- 14. Department of Biosciences and Nutrition, Karolinska Institutet, Hälsovägen 7, 14183 Huddinge, Sweden.
- 15. Center for Innovative Medicine, Karolinska Institutet, Hälsovägen 7, 14183 Huddinge, Sweden.
- # Contributed equally.
Monogenic causes of autoimmunity provide key insights into the complex regulation of the immune system. We report a new monogenic cause of autoimmunity resulting from de novo germline activating STAT3 mutations in five individuals with a spectrum of early-onset Autoimmune Disease, including Type 1 Diabetes. These findings emphasize the critical role of STAT3 in Autoimmune Disease and contrast with the germline inactivating STAT3 mutations that result in hyper IgE syndrome.